Table 1 Clinical characteristics of high and low mRNAi samples
Characteristics | N of cases | mRNAsi level | P-value | |
|---|---|---|---|---|
Low | High | |||
Age (years) | ||||
 ≤ 60 | 107 | 65 | 42 | 1.20E−02 |
 > 60 | 382 | 179 | 203 | |
Gender | ||||
 Male | 366 | 181 | 185 | 7.58E−01 |
 Female | 128 | 66 | 62 | |
Pathologic M | ||||
 M0 | 406 | 211 | 195 | 2.71E−01 |
 M1 | 7 | 2 | 5 | |
Pathologic N | ||||
 N0 | 316 | 151 | 165 | 3.70E−01 |
 N1 | 127 | 68 | 59 | |
 N2 | 40 | 24 | 16 | |
 N3 | 5 | 2 | 3 | |
Pathologic T | ||||
 T1 | 114 | 48 | 66 | 1.39E−01 |
 T2 | 287 | 154 | 133 | |
 T3 | 70 | 36 | 34 | |
 T4 | 23 | 9 | 14 | |
Pathologic stage | ||||
 Stage I | 242 | 116 | 126 | 4.85E−01 |
 Stage II | 158 | 82 | 76 | |
 Stage III | 83 | 45 | 38 | |
 Stage IV | 7 | 2 | 5 | |
Tumor recurrence | ||||
 Yes | 100 | 51 | 49 | 9.98E−01 |
 No | 286 | 144 | 142 | |
Radiotherapy | ||||
 Yes | 50 | 31 | 19 | 7.19E−02 |
 No | 376 | 181 | 195 | |